Oxygenation status of primary and recurrent squamous cell carcinomas of the vulva

Introduction: Cancers of the vulva are relatively rare and, therefore, little is known about the pathophysiological role of tumor oxygenation in this entity.

Methods: Data are presented on the oxygenation status of primary (n = 15) and recurrent (n = 19) cancers of the vulva, as measured by the Eppendorf pO2 histography system.

Results: Contrary to other tumor entities, no significant differences in the oxygenation status between primary (median pO2 = 13 mmHg; hypoxic fraction < or = 5 mmHg = 37%) and recurrent (median pO2 = 11 mmHg; hypoxic fraction < or = 5 mmHg = 45%) tumors were found. Oxygenation was significantly lower in cancers of the vulva than in the subcutis. Anemic patients had significantly poorer tumor oxygenation compared with patients whose cHb values were within the normal range (p = 0.02).

Conclusions: The oxygenation of vulvar cancers is similar to other tumor entities, but does not show more severe hypoxia in recurrent cases. Anemia is associated with a poorer oxygenation status in vulvar cancers, whereas in the normal tissue no impact of cHb values on the median pO2 was observed.

Vulvar cancer; Tumor hypoxia; Tumor Oxygenation; Oxygen measurements; Anemia

[1] Brahimi-Hom C., Mazure N., Pouyssegur J.: "Signaling via the hypoxia-inducible factor-1 alpha requires multiple posttranslational modifications". Cell. Signal., 2005, 17, 1.

[2] Iyer N.V., Kotch L.E., Agani F., Leung S.W., Laughner E., Wenger R.H. et al.: "Cellular and developmental control of 02 homeostasis by hypoxia-inducible factor l alpha". Genes. Dev., 1998, 12, 149.

[3] Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., Semenza G.L.: "Reciprocal positive regulation of hypoxia-inducible factor 1 a and insulin-like growth factor 2". Cancer Res., 1999, 59, 3915.

[4] Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J. et al.: "Hypoxia-inducible factor-I modulates gene expression in solid tumors and influences both angiogenesis and tumor growth". Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 8104.

[5] Krishnamachary B., Berg-Dixon S., Kelly B., Agani F., Feldser D., Ferreira G. et al.: "Regulation of colon carcinoma cell invasion by hypoxia-inducible factor l ". Cancer Res., 2003, 63, 1138.

[6] Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P.M.: "Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene". Cancer Cell, 2003, 3, 347.

[7] Comerford K.M., Wallace T.J., Karhausen J., Louis N.A., Montalto M.C., Colgan S.P.: "Hypoxia-inducible factor-I-dependent regulation of the multidrug resistance (MORI) gene". Cancer Res., 2002, 62, 3387.

[8] Vaupel P., Mayer A., Hocke] M.: "Tumor hypoxia and malignant progression". Methods Enzymol., 2004, 381, 335.

[9] Loeb L.A.: "Mutator phenotype may be required for multistage carcinogenesis". Cancer Res., 1991, 51, 3075.

[10] Yuan J., Narayanan L., Rockwell S., Glazer P.M.: "Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH". Cancer Res., 2000, 60, 4372.

[11] Russo C.A., Weber T.K., Volpe C.M., Stoler D.L., Petrelli N.J., Rodriguez-Bigas M. et al.: "An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer". Cancer Res., 1995, 55, 1122.

[12] Coquelle A., Toledo F., Stern S., Bieth A., Debatisse M.: "A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs". Mal. Cell, 1998, 2, 259.

[13] Mihaylova V.T., Bindra R.S., Yuan J., Campisi D., Narayanan L., Jensen R., et al.: "Decreased expression of the DNA mismatch repair gene Mlhl under hypoxic stress in mammalian cells". Mal. Cell. Biol., 2003, 23, 3265.

[14] Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch CJ., Lowe S.W. et al.: "Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours". Nature, 1996, 379, 88.

[15] Hocke] M., Vorndran B., Schlenger K., Baussrnann E., Knapstem P.G.: "Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix". Gynecol. Oneal., 1993, 51, 141.

[16] Hocke! M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P.: "Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix". Cancer Res., 1996, 56, 4509.

[17] Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., Dewhirst M.W.:'Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck". Int. J. Radial. Oneal. Biol. Phys., 1997, 38, 285.

[18] F yles AW., Milosevic M., Wong R., Kavanagh M.C., Pintilie M., Sun A. et al.: "Oxygenation predicts radiation response and survival in patients with cervix cancer". Radiother. Oneal., 1998, 48, 149.

[19] Sundfor K., Lyng H., Rofstad E.K.: "Tumour hypoxia and vascuJar density as predictors of metastasis in squamous cell carcinoma of the uterine cervix". Br. J. Cancer, 1998, 78, 822.

[20] Hocke! M., Schlenger K., Hocke] S., Vaupel P.: "Hypoxic cervical cancers with low apoptotic index are highly aggressive". Cancer Res., 1999, 59, 4525.

[21] Nordsmark M., Overgaard J.:'Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer". Acta Oneal., 2004, 43, 396.

[22] Nordsmark M., Alsner J., Keller J., Nielsen 0.S., Jensen O.M., Horsman M.R. et al.: "Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations". Br. J. Cancer, 2001, 84, 1070.

[23] Rosen C., Malmstrom H.: "Invasive cancer of the vulva". Gynecol. Oncol., 1997, 65, 213.

[241 Stone J.E., Parker R., Gilks C.B., Stanbridge E.J., Liao S.Y., Aquino-Parsons C.: "Intratumoral oxygenation of invasive squamous cell carcimoma of the vulva is not correlated with regional lymph node metastasis". Eur. J. Gynaecol. Oncol., 2005, 26, 31.

[25] Vaupel P., Thews 0., Mayer A., Hocke! S., Hocke! M.: "Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level?". Strahlenther. Onkol., 2002, 178, 727.

[26] Hockel M., Schlenger K., Knoop C., Vaupel P.: "Oxygenation of catcinomas of the uterine cervix: evaluation by computerized 02 tension measurements". Cancer Res., 1991, 51, 6098.

[27] Merzlufft F.: " Normal values for hemoglobin concentration". In: Zander R., Merzlufft F. (eds.), The Oxygenation Status of Arterial Blood. New York: Karger, 1991, 162.

[28] Thomas L.: "Hamoglobine". ln: Thomas L. (ed.), Labor und Diagnose. F rankfurt: TH Books Verlagsgesellschaft, 1998, 487.

[29] Hockel M., Schlenger K., Hocke! S., Aral B., Schaffer U., Vaupel P.: "Tumor hypoxia in pelvic recurrences of cervical cancer". Int. J. Cancer, 1998, 79, 365.

[30] Kehrl W., Sagowski C., Wenzel S., Zywietz F.: "Oxygenation of tumor recurrences following fractionated radiotherapy of primary tumors. Studies on the rhabdomyosarcoma RlH of the rat". Strahlenther. Onkol., 2004, 180, 383.

[31] Hockel M., Domhofer N.: "The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection" Cancer Res., 2005, 65, 2997.

[32] Rouzier R., Haddad B., Plantier F., Dubois P., Pelisse M., Paniel B.J.: "Local relapse in patients treated for squamous cell vul var carcinoma: incidence and prognostic value". Obstet. Gynecol., 2002, 100, 1159.

[33] Vaupel P.,Mayer A.: "Erythropoietin to treat anaemia in patients with head and neck cancer". Lancet, 2004, 363, 992.

[34] Vaupel P ., Thews O., Hoeckel M.: "Treatment resistance of solid tumors: Role of hypoxia and anemia". Med. Oncol., 2001, 18, 243.

[35] Vaupel P., Mayer A., Briest S., Hockel M.: "Oxygenation gain factor: a novel parameter chatacterizing the association between hemoglobin level and the oxygenation status of breast cancers". Cancer Res., 2003, 63, 7634.